SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-041834
Filing Date
2017-06-27
Accepted
2017-06-27 16:43:21
Documents
1
Period of Report
2017-06-23

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1452
  Complete submission text file 0001104659-17-041834.txt   2900
Mailing Address C/O TREVENA, INC. 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address
Bourdow Carrie L. (Reporting) CIK: 0001638989 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38132 | Film No.: 17932840

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640
Nabriva Therapeutics Plc (Issuer) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations